Signal active
Investment Firm
Overview
Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful teams, win key customers, and navigate acquisitions and IPOs. Sofinnova Ventures invests in Life Science and Technology start-ups. Their professionals are seasoned business operators, possessing deep domain and investment expertise. They know how to help entrepreneurs build successful, global businesses.
Highlights
1974
Financial Services
11-50
300
76
118
Late Stage Venture, Early Stage Venture, Seed, Private Equity
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Sofinnova Investments, established in 1974 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Mobile, Digital Media, Telecommunications, Broadcasting, Software, Natural Language Processing, Artificial Intelligence (AI), Machine Learning, Predictive Analytics, Wireless. The organization boasts a portfolio of 300 investments, with an average round size of $43.4M and 118 successful exits. Their recent investments include Streamezzo, Qualcomm, I-Source Gestion, Ardian, Sofinnova Partners. The highest investment round they participated in was $1021.5B. Among their most notable exits are Streamezzo and Qualcomm. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
300
34
76
118
Investments
300
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Mar 26, 2024 | Avenzo Therapeutics | Biotechnology | 150.0M |
Mar 28, 2024 | - | - | 50.0M |
Apr 09, 2024 | Seaport Therapeutics | Biotechnology | 100.0M |
Jun 18, 2024 | - | - | 190.0M |
Exits
118
Funding Timeline
300
0
4
Funding Rounds
300
Sofinnova Investments has raised 300 rounds. Their latest funding was raised on Jun 18, 2024 from a Series B - Marea Therapeutics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Mar 26, 2024 | Series A - Avenzo Therapeutics | - | 150.0M | - |
Mar 28, 2024 | Series A - Aeovian Pharmaceuticals | - | 50.0M | - |
Apr 09, 2024 | Series A - Seaport Therapeutics | - | 100.0M | - |
Jun 18, 2024 | Series B - Marea Therapeutics | - | 190.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.